When & How to Use Changed Clinical Laboratory Consult Codes
Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
Use of these codes has frequently raised concerns for compliance due to a lack of clarity regarding when they’re appropriate.
Agency warns the public to be on the lookout as counterfeit at-home OTC COVID-19 diagnostic tests appear on the US market.
New report shows a fair portion of prior authorization and physician reimbursement request denials actually met Medicare coverage rules.
In this month’s Business Roundup, we cover key happenings including Medicare coverage and reimbursement, as well as the US surpassing Europe as medtech’s market of choice.
In last week’s announced enforcement actions involving the healthcare industry, two defendants were sentenced, one was convicted, and two others were charged in various fraud-related schemes.
Case is part of a larger coordinated enforcement action targeting COVID-19-related fraud spanning seven judicial districts.
A research team has developed a new, simpler microfluidic chip that could make at-home diagnosis of diseases faster and more affordable
For the third straight year since the PAMA pricing system has been in place, overall year-over-year spending on lab tests increased in FY 2020.
Healthcare M&A might have bottomed out in the first quarter of 2022 in terms of both deal volume and size, according to a new report.
InspectIR COVID-19 device detects the virus from breath samples in less than three minutes, offering a new screening option.
The recently-formed Precision Cancer Consortium will make it easier for cancer patients around the world to get access to genomic testing.